It can take up to 15 years and about $2.5 billion to develop a new drug treatment, so anything with the potential to shorten this cycle is going to pique the interest of the pharma sector worldwide.

A domestic research team has developed a groundbreaking technology that solves one of the critical obstacles in the new drug development process, known as the "simultaneous analysis" problem, becoming ...

SK Biopharm announced on the 18th that it has signed a strategic business agreement with the AI company Phoenix Lab (PhnyX Lab) to establish an AI-based new drug development system. The signing ...

Researchers are exploring how protein crystals produced in a zero-gravity environment like space could lead to more effective drugs ...

[Asia Economy Reporter Chunhee Lee] Many pharmaceutical and biotech companies challenge themselves in the new drug development process by applying for the U.S. Food and Drug Administration (FDA) ...

As the U.S. Food and Drug Administration (FDA) announced its plan to phase out animal testing obligations in the drug development process, companies related to animal replacement tests such as ...

In 2021, the number of drug regulatory submissions to the U.S. Food and Drug Administration (FDA) based on machine learning increased about tenfold (132 submissions) compared to 2020. This serves as ...

CRDMOs offer a continuum of services from early discovery to clinical manufacturing, addressing solubility and stability challenges in NCE development. Advanced technologies like spray drying and ...

Wouldn’t it be ideal to observe how a medicine behaves in organs like the liver, intestines, and kidneys before testing it in living humans or animals? TNO’s new multi-organ perfusion model makes this ...

FDA consumer safety officer discussed the challenges of navigating policy and politics in rare diseases at a recent meeting.

The process of transforming a concept into a drug involves careful planning and multiple stages. It begins with identifying a therapeutic target, such as a protein or enzyme linked to a specific ...

In 2019, VHI became the first Irish health insurer to cover the cost of novel cancer drugs for cancer patients once they had been approved by the European Medicines Agency (EMA). At the time, Irish ...